Evaluation of Treatment for Leukoderma by Cellular Level Resolution Full-field Optical Coherence Tomography

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Leukoderma
Interventions
DEVICE

ApolloVue® S100 Image System (Apollo Medical Optics)

The device is an in vivo non-invasive optical coherence tomography and will be used to obtain at least 6 medical images of normal and lesional skin, respectively, for both experimental group and control group. The ApolloVue S100 image system is a high resolution OCT imaging system that provide real-time visualization of human skin tissue microstructure. The system provides cellular level, two-dimensional, cross-sectional (B-scan) and en face (E-scan) that can assist clinical diagnosis.The system is also equipped with imaging guiding system that could assist in position scanning skin area.

Trial Locations (1)

33305

Linkou Chang Gung Memorial Hospital, Taoyuan

All Listed Sponsors
collaborator

Apollo Medical Optics, Ltd

INDUSTRY

lead

Chang Gung Memorial Hospital

OTHER

NCT04935424 - Evaluation of Treatment for Leukoderma by Cellular Level Resolution Full-field Optical Coherence Tomography | Biotech Hunter | Biotech Hunter